Category

Blastoma

Glioblastoma Multiforme Treatment Market is a growing market into the Healthcare sector at present years. Blastoma

Glioblastoma Multiforme Treatment Market is a growing market into the Healthcare sector at present years.

Glioblastoma Multiforme Treatment Industry Overview The global glioblastoma multiforme treatment market size was valued at USD 2.14 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. The growing prevalence of glioblastoma multiforme, increasing R&D, and favorable regulatory scenarios…
bubmag
October 13, 2022
Researchers identify Achilles’ heel in neuroblastoma | Mirage News Blastoma

Researchers identify Achilles’ heel in neuroblastoma | Mirage News

Neuroblastoma, a childhood cancer that develops from neural cells on the adrenal glands, accounts for 15% of childhood cancer deaths. Almost half of children with high-risk neuroblastoma harbor extra copies of the gene MYCN (MYCN amplified), the primary driver of neuroblastoma and its resistance to therapy. “Treating neuroblastoma by directly…
bubmag
August 16, 2022
Study identifies aggressive cancer that hijacks the brain to make itself incurable Blastoma

Study identifies aggressive cancer that hijacks the brain to make itself incurable

Brain cancer may be rare, but glioblastoma (also known as glioblastoma multiforme or GBM) accounts for around 15 percent of brain tumors. The aggressive cancer is well known within the medical field due to being one of the most dangerous cancers around. Now, scientists may better understand why GBM is…
bubmag
July 29, 2022
Early, encouraging data for glioblastoma treatment reported at ASCO Blastoma

Early, encouraging data for glioblastoma treatment reported at ASCO

Glioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0 All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival. Glioblastoma multiforme…
bubmag
June 11, 2022
Cancer Outcome Disparities Not Fully Explained by Race, Socioeconomic Factors Blastoma

Cancer Outcome Disparities Not Fully Explained by Race, Socioeconomic Factors

Enrollment in clinical trials failed to overcome factors leading to worse survival for Hispanic children with high-risk neuroblastoma, a large retrospective analysis showed. The Hispanic subgroup had a 5-year overall survival (OS) rate of 47% as compared with over 60% for whites and non-Hispanic Blacks. A similar disparity was seen…
bubmag
May 27, 2022
Kidscan Children’s Cancer Research and North West Cancer Research are proud to announce joint funding of a £75k research grant specifically targeting childhood cancer. Blastoma

Kidscan Children’s Cancer Research and North West Cancer Research are proud to announce joint funding of a £75k research grant specifically targeting childhood cancer.

Kidscan are working together with North West Cancer Research to jointly fund a three-year PhD grant for a scientist working in the area of childhood cancer whose research focuses on Medulloblastoma, or who can illustrate how their work could also be relevant to Medulloblastoma. Alastair Richards, CEO of North West…
bubmag
May 23, 2022